It is not often that one’s first meeting of the day starts with an exquisite rendering of a 19th Century Danish hymn by a quartet of professional musicians. The singing along with a crisp, cloudless but decidedly chilly Copenhagen morning served to kick-start a day-long discussion of how Novo Nordisk, the Danish pharmaceutical company1, should go about creating ‘sustainable value’.
